Overview

Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

Status:
COMPLETED
Trial end date:
2025-06-28
Target enrollment:
Participant gender:
Summary
Drug-drug interaction study between Omeprazole and Bemnifosbuvir/Ruzasvir (BEM/RZR)
Phase:
PHASE1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Treatments:
Lead
Omeprazole